Ex. 3005 | Jul 23, 2024 | EXHIBIT | BOARD |
Ex. 3004 | Jul 23, 2024 | EXHIBIT | BOARD |
Adverse judgment: post-institution | Jul 23, 2024 | PAPER | BOARD |
Institution Decision: Joined | Jan 30, 2024 | PAPER | BOARD |
Order: Conduct of Proceeding | Jan 26, 2024 | PAPER | BOARD |
Notice : Mandatory Notice | Jan 3, 2024 | PAPER | PATENT OWNER |
Notice : Power of Attorney | Jan 3, 2024 | PAPER | PATENT OWNER |
Notice: Notice filing date accorded | Dec 28, 2023 | PAPER | BOARD |
U.S. Patent No. 11,253,572 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regeneron 2009 Press Release | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regeneron December 2010 Press Release | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regeneron November 2010 Press Release | Dec 14, 2023 | EXHIBIT | PETITIONER |
Apotex Petition for IPR 2022-01524 (Paper 1) | Dec 14, 2023 | EXHIBIT | PETITIONER |
Dixon et al., Opinion 2009 | Dec 14, 2023 | EXHIBIT | PETITIONER |
2010 ARVO Abstract 2010 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Mylan v. Regeneron, IPR2022-01225 (Paper 21) Institution Decision | Dec 14, 2023 | EXHIBIT | PETITIONER |
Mylan v. Regeneron, IPR2022-01226 (Paper 22) Institution Decision | Dec 14, 2023 | EXHIBIT | PETITIONER |
Certified Prosecution History of U.S. Patent No. 11,253,572 - Part 1 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Certified Prosecution History of U.S. Patent No. 11,253,572 - Part 2 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Certified Prosecution History of U.S. Patent No. 11,253,572 - Part 3 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Certified Prosecution History of U.S. Patent No. 11,253,572 - Part 4 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Adis R&D Profile 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Hecht, “Opthalmic Preparations,” 1995 | Dec 14, 2023 | EXHIBIT | PETITIONER |
WO 2006/047325 Al (“Shams”) | Dec 14, 2023 | EXHIBIT | PETITIONER |
Elman 2010 Randomized Trial | Dec 14, 2023 | EXHIBIT | PETITIONER |
Elman AAO Website 2010 | Dec 14, 2023 | EXHIBIT | PETITIONER |
CATT Study, Authenticating Affidavit and the July 13, 2010 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regillo CD, PIER Study, 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Lucentis-Avastin Trial NCT-450 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regillo CD, PIER AJO Website, 2007 | Dec 14, 2023 | EXHIBIT | PETITIONER |
History of Changes for Study NCT-623 | Dec 14, 2023 | EXHIBIT | PETITIONER |
ClinicalTrials.gov Background | Dec 14, 2023 | EXHIBIT | PETITIONER |
ClinicalTrials.gov About the Results Database | Dec 14, 2023 | EXHIBIT | PETITIONER |
Regeneron Report Positive Phase 1 Data, May 2, 2006 Press Release | Dec 14, 2023 | EXHIBIT | PETITIONER |
Nguyen QD et al, Phase I Study, Nov. 2009 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Bayer and Regeneron Dose First Patient in Second Phase 3, PR, May 8, 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Do DV et al., ARVO Abstract, 2007 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Do DV et al, DA VINCI Study, May 5, 2011 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Randolph and Jones, “Surfactant-Protein Interactions,” , 2002 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Fraser et al., Journal of Clinical Endocrinology and Metabolism, Feb. 2005 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Lucentis ® Original Approved Labeling (2006) | Dec 14, 2023 | EXHIBIT | PETITIONER |
Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap, 2002 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Rudge JS, Thurston G. Davis S. et al., VEGF trap as a novel, 2005 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Gomez-Manzano C, Holash J, Fueyo J, et al. VEGF Trap, "Gomez-Manzano" 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Heier JS, et al., 2012 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Heier JS, et al., 2011 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Pai A et al., 2010 | Dec 14, 2023 | EXHIBIT | PETITIONER |
U.S. Patent App. Pub. US 2007/0190058A1 (“Shams US App. Pub.”) | Dec 14, 2023 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,254,338 (“’338 patent”) | Dec 14, 2023 | EXHIBIT | PETITIONER |
WO 2012/097019A1 (“Yancopoulos PCT Application”) | Dec 14, 2023 | EXHIBIT | PETITIONER |
NIH DR, Sept. 2015 | Dec 14, 2023 | EXHIBIT | PETITIONER |
NIH AMD Sept. 2015 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Halpern 2006 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Rudge 2007 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Li 2020 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Brown 2009 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Martin Two-Year Results 2012 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Chakravarthy 2012 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Rosenfeld 2006 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Heimann 2007 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Jager 2004 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Certified Prosecution History of U.S. Patent No. 10,130,681 B2 | Dec 14, 2023 | EXHIBIT | PETITIONER |
MACTEL Study, May 24, 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
MACTEL Study Wayback Machine, Nov. 7, 2008 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Using the Wayback Machine | Dec 14, 2023 | EXHIBIT | PETITIONER |
Eylea Label 2011 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Glenn J. Jaffe et al., Intraoculaar Drug Delivery, 2006 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Steps for a Safe Intravitreal Injection Technique, 2009 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Mylan April 10 Motion, Case No. 1:22-cv-00061-TAKS, N.D. WV., Dkt. 415. | Dec 14, 2023 | EXHIBIT | PETITIONER |
Mylan Litigation CC Order, Case No. 1:22-cv-00061-TSK, N.D. WV. , Dkt. 427. | Dec 14, 2023 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,531,173 (“’173 patent”) | Dec 14, 2023 | EXHIBIT | PETITIONER |
Institution Decision in Apotex Inc. v. Regeneron IPR2022-01524 | Dec 14, 2023 | EXHIBIT | PETITIONER |
Mylan v. Regeneron, IPR2021-00881 (Paper 94) Final Written Decision | Dec 14, 2023 | EXHIBIT | PETITIONER |
Curriculum Vitae of Christine Nichols Kay, M.D. | Dec 14, 2023 | EXHIBIT | PETITIONER |
Declaration of Dr. Christine Kay | Dec 14, 2023 | EXHIBIT | PETITIONER |
Inter Partes Review Petition of U.S. Patent 11,253,572 | Dec 14, 2023 | PAPER | PETITIONER |
Petitioner's Power of Attorney | Dec 14, 2023 | PAPER | PETITIONER |
Motion : Joinder | Dec 14, 2023 | PAPER | PETITIONER |